These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2413317

  • 1. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T, Nolasco I, Hibbin J, Goldman JM.
    Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
    [Abstract] [Full Text] [Related]

  • 2. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T, Dowding C, Garewal G, Hibbin JA, Th'ng KH, Goldman JM.
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [Abstract] [Full Text] [Related]

  • 3. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1987 Sep; 35(4):519-29. PubMed ID: 3481543
    [Abstract] [Full Text] [Related]

  • 4. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Sep; 36(4):471-85. PubMed ID: 3074744
    [Abstract] [Full Text] [Related]

  • 5. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.
    Goldman JM, Hibbin J, Kearney L, Orchard K, Th'ng KH.
    Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244
    [Abstract] [Full Text] [Related]

  • 6. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Nov; 36(1):71-84. PubMed ID: 3233065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Nov; 36(6):733-47. PubMed ID: 3254121
    [Abstract] [Full Text] [Related]

  • 11. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA, Herrmann F, Davis R, Nichols K, Griffin JD.
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [Abstract] [Full Text] [Related]

  • 12. Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow.
    Ferrero D, Broxmeyer HE, Pagliardi GL, Venuta S, Lange B, Pessano S, Rovera G.
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4114-8. PubMed ID: 6191330
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 15. GM 58/8: a monoclonal antibody that identifies a new lineage-specific determinant expressed by myeloid progenitors (CFU-GM) and their progeny.
    Das Gupta A, Brice M, Yokochi T, Papayannopoulou T, Stamatoyannopoulos G.
    Br J Haematol; 1984 Sep 15; 58(1):147-58. PubMed ID: 6205677
    [Abstract] [Full Text] [Related]

  • 16. Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E.
    Pelus LM, Saletan S, Silver RT, Moore MA.
    Blood; 1982 Feb 15; 59(2):284-92. PubMed ID: 6173083
    [Abstract] [Full Text] [Related]

  • 17. Failure of bone marrow cryopreservation in chronic granulocytic leukemia: relation to excessive granulo-macrophagic progenitor pool.
    Douay L, Lopez M, Gorin NC, Nauman A, Giarratana MC, Laporte JP, Stachowiak J, Salmon C, Duhamel G.
    Int J Cell Cloning; 1986 Jul 15; 4(4):250-62. PubMed ID: 2875118
    [Abstract] [Full Text] [Related]

  • 18. Complement-dependent cytotoxicity in the analysis of antigenic determinants on human hematopoietic progenitor cells with HLA-DR as a model.
    Falkenburg JH, van der Vaart-Duinkerken N, Veenhof WF, Goselink HM, van Eeden G, Parlevliet J, Jansen J.
    Exp Hematol; 1984 Dec 15; 12(11):817-21. PubMed ID: 6210206
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
    Lu L, Pelus LM, Broxmeyer HE.
    Exp Hematol; 1984 Oct 15; 12(9):741-8. PubMed ID: 6436046
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
    Kubota Y, Tanaka T, Irino S.
    Leuk Res; 1991 Oct 15; 15(4):195-204. PubMed ID: 2030600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.